ERNEST BRIËT, M. D.; MERK C. WIJNANDS, M.D.; JAN J. VELTKAMP, M.D.
Hemophilia B Leyden is an X-linked recessively inherited bleeding disorder that cannot be distinguished from severe cross-reactive material-negative hemophilia B in patients under 15 years of age. After puberty, however, the hemorrhagic symptoms diminish and the factor IX levels begin to rise (1, 2). Until now, the cases of two unrelated families with this disease have been reported: one in the Netherlands (1, 2) and one in Greece (Mandalaki T, Louizou C, Dimitriadou C. Haemophilia B Leyden in Greece. Presented at the 13th Congress of the World Federation of Hemophilia, Tel Aviv, Israel, 8-13 July 1979). The close association of
Learn more about subscription options.
Register Now for a free account.
BRIËT E, WIJNANDS MC, VELTKAMP JJ. The Prophylactic Treatment of Hemophilia B Leyden with Anabolic Steroids. Ann Intern Med. 1985;103:225–226. doi: 10.7326/0003-4819-103-2-225
Download citation file:
Published: Ann Intern Med. 1985;103(2):225-226.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only